This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Everest Group Recognizes Cognizant As A Global Leader And Star Performer In Healthcare Payer IT Outsourcing

Stocks in this article: CTSH

TEANECK, N.J., Sept. 10, 2013 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been named a global Leader and Star Performer in healthcare payer IT outsourcing by Everest Group, an advisory and research firm on global services.

Everest Group evaluated 15 global healthcare payer IT service providers in the recently released report ' IT Outsourcing in Healthcare Payer Industry -- Service Provider Landscape with PEAK Matrix™ Assessment and Profile Compendium 2013'.

Cognizant was named a Leader, the highest rating according to Everest Group's PEAK Matrix™ framework, on the basis of overall market success and delivery capability. While market success was based upon annualized contract value, delivery capability was measured by the ability to deliver services successfully along the four sub-dimensions of scale, scope, domain investments, and delivery footprint. Cognizant was also awarded the Star Performer rating based on year-on-year movement on the PEAK Matrix™ and top performance in both market success and capability advancement.

According to Everest Group, Leaders have a larger scale along with broader and deeper client relationships, higher technology capability and investment in tools and platforms, and wider delivery footprint and global delivery presence. "Cognizant positioned itself as a global Leader in the payer ITO services showing strong growth even on a large revenue base," the report stated. "Cognizant strengthened its Leadership position by investing significantly in its payer ITO talent base, adding new clients, and scale during the year." It added, "Cognizant has one of the most extensive large-deal portfolios as well as the highest annual growth rate in the payer ITO segment."

"The healthcare industry has witnessed rapid adoption of consulting, IT and business process services in the recent years as a result of regulatory reform, consumerization of healthcare, market consolidation, and emergence of new technologies," said Jimit Arora, Vice President of Everest Group. "Cognizant is among a handful of service providers catering to the global market that have achieved success with large-sized, multi-year service contracts. Cognizant has not only continued to maintain its position as a Leader, but also substantially enhanced its capabilities and thought leadership to drive innovation and be a Star Performer. Cognizant's growth underscores the strong preference that payers have shown for service providers with large and balanced portfolio of offerings."

"This recognition by Everest Group underscores Cognizant's distinctive ability to enable payer organizations to address long-term secular shifts in the business, regulatory and technology environments," said Krish Venkat, Executive Vice President of Cognizant's Healthcare and Life Sciences practice. "We are increasingly helping payers to not just run better by driving efficiencies across the value chain, but also run different by engaging more effectively with consumers and launching newer products and services to support membership growth in an industry that is fundamentally shifting towards consumerism.

"Transformative priorities such as Health Insurance Exchanges, health and wellness initiatives, support for the dual-eligible population, and accountable care are at the forefront of our customers' agenda. With a comprehensive portfolio of consulting solutions, insight-driven analytics, and business process and IT implementation services, Cognizant helps payers turn these challenges into opportunities for strategic differentiation by anticipating not just how they will evolve, but also how developments across other industry segments will affect their business models. By further enabling payers to build new capabilities on the back of social, mobility, analytics and cloud technology architectures, Cognizant enables them to improve quality of care, enhance customer engagement, optimize operations and processes, and rationalize administrative as well as medical costs," Krish Venkat added. 

About Cognizant's Healthcare and Life Sciences Practice

Cognizant's Healthcare and Life Sciences practice is committed to helping change millions of lives for the better by partnering with clients to build solutions to healthcare challenges, continually improve the way they do business, set the pace in clinical development, strengthen their regulatory infrastructure, and increase competitiveness. Consistently ranked among the top 10 on the Healthcare Informatics Top 100, Cognizant serves 27 of the top 30 global pharmaceutical companies, 15 of the top 20 health plans in the U.S., 5 of the top 6 pharmacy benefit management companies in the U.S., 9 of the top 10 biotech companies, and 12 of the top 20 medical device companies. With a large team of dedicated professionals including doctors, pharmacologists, physicians, biomedical engineers, pharmacists, biostatisticians, medical writers, and GxP consultants, the practice provides domain-aligned consulting, IT, business process and analytics solutions globally.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs